Members of the voltage-gated K + (K V ) channel family are suggested to control the resting membrane potential and the repolarization phase of the action potential in urinary bladder smooth muscle (UBSM). Recent studies report that stromatoxin-1, a peptide isolated from tarantulas, selectively inhibits K V 2.1, K V 2.2, K V 4.2 and K V 2.1/9.3 channels. The objective of this study was to investigate whether K V channels sensitive to stromatoxin-1 participate in the regulation of rat UBSM contractility and to identify their molecular fingerprints. Stromatoxin-1 (100 nM) increased the spontaneous phasic contraction amplitude, muscle force, and tone in isolated UBSM strips. However, stromatoxin-1 (100 nM) had no effect on the UBSM contractions induced by depolarizing agents such as KCl (20 mM) or carbachol (1 µM). This indicates that under conditions of sustained membrane depolarization, the K V channels sensitive to stromatoxin-1 have no further contribution to the membrane excitability and contractility. Stromatoxin-1 (100 nM) increased the amplitude of the electrical field stimulation induced contractions, suggesting also a role for these channels in neurogenic contractions. RT-PCR experiments on freshly isolated UBSM cells showed mRNA expression of K V 2.1, K V 2.2, and K V 9.3 but not K V 4.2 channel subunits. Protein expression of K V 2.1 and K V 2.2 channels was detected using
Introduction
During the bladder-filling phase, urinary bladder smooth muscle (UBSM) relaxes to accommodate increasing volumes of urine. During voiding, the UBSM contracts in a phasic manner to expel the urine. A key regulator of UBSM contractility is the cell membrane potential (3, 6, 7, 13, 16, 24) . Spontaneous action potentials determine the phasic nature of the contractions in UBSM (6, 14, 16, 23, 24) . Ca 2+ entry through L-type voltage-gated Ca 2+ channels is responsible for the upstroke of the action potential and leads to an increase in the intracellular Ca 2+ concentration which initiates the UBSM phasic contractions (14) . The repolarization phase of the UBSM action potential is mediated by the activity of the large conductance Ca
2+
-activated K + (BK) channels (6, 14, 16, 23, 24) and perhaps the voltage-gated K + (K V ) channels (13, 28) . After the repolarization phase, the action potential in UBSM displays a prolonged after-hyperpolarization, which is mediated by apamin-sensitive small conductance Ca 2+ -activated K + (SK) channels (15) and perhaps K V channels (12, 13) . The UBSM resting membrane potential is controlled by the BK, ATP-sensitive K + (K ATP ), and probably K V channels (12-14, 24, 28) . In essence, various K + channels, including K V channels, play differential roles in regulating both UBSM resting membrane potential and action potentials, and therefore the related phasic contractions.
Normally, the K V 1-4, K V 7, and K V 10-12 subunits form homotetramers. Interestingly, K V 5, K V 6, K V 8, and K V 9 channels do not make their own homotetramers but rather form heterotetramers with the K V 2 subunits (22) . For example, association of K V 2.1 and K V 9.3 subunits can produce oxygen-sensitive K + channels (17, 20, 21) . The K V channels have diverse biophysical and pharmacological properties in different smooth muscles, playing a prominent role in shaping the electrical and contractile behavior (1, 27) . The tissue specificity, diverse properties, and various functions of the K V channels make them selective drug targets for diseases such as overactive bladder (4, 22) .
In mouse UBSM, K V 2, K V 5, and K V 6 channel subunits are probable candidates for mediating the repolarization phase of the action potential and in maintaining the resting membrane potential (28) . In contrast, recent studies on mouse UBSM argue that K V 2.1
does not play a role in shaping the action potential (13) . The K V 1 channels are shown to be expressed and functional in human UBSM (8) . In vivo studies suggest a role for K V 7
(KCNQ) channels in rat bladder function (26) . However, knowledge about the role of the K V channels in UBSM contractility is limited and controversial (8, 11, 13, 28) .
In the past, the lack of specific K V channel inhibitors has hampered the study of these channels. The emergence of new, highly specific K V channel inhibitors, have enabled researchers to selectively isolate K V channel subtypes and determine their physiological role (22) . Stromatoxin-1, a 34-amino acid peptide isolated from African tarantulas, was shown to selectively inhibit K V 2.1, K V 2.2 and K V 4.2 homotetramers, and K V 2.1/9.3 heterotetramers with high affinity (9, 10) . This recent discovery enables us to employ stromatoxin-1 as a tool to dissect the role of these K V channels in UBSM contractility.
The goal of the present study was to examine the functional role of the K V channels sensitive to stromatoxin-1 in regulating rat UBSM contractility. Using molecular biology approaches we further identified the expression of the individual K V channels sensitive to stromatoxin-1. We detected mRNA expression of K V 2.1, K V 2.2 and K V 9.3 subunits in freshly isolated UBSM cells, and confirmed K V 2.1 and K V 2.2 protein expression by Western blot and immunocytochemical methods. We revealed that K V 2.1 and K V 2.2 channels play a key role in opposing rat UBSM myogenic and nerve-evoked contractions.
MATERIALS AND METHODS

Animal care, tissue and cell preparation
All animal studies were carried out in accordance with the Animal Use Protocol #1482 Bladders were then dissected free of fat and connective tissue. The trigone, urethra, and ureter sphincters were also removed, and only detrusor muscle (referred to as "UBSM" throughout) was used in the study.
For RT-PCR experiments, UBSM whole tissue and freshly isolated single cells were immediately used for RNA extraction. UBSM single cells for RT-PCR and immunocytochemistry were freshly isolated and collected as previously described (7, 16) .
For RT-PCR and Western blot experiments, the rat brains were also removed and placed in ice-cold Ca
2+
-free dissection solution (see above).
Isometric UBSM tension recordings
Isometric UBSM tension recordings were conducted, as previously described (16) .
Briefly, small UBSM strips (1-2 mm wide and 5-7 mm long) were cut from the bladder and transferred to a small vial containing Ca
2+
-free dissection solution (see above). The strips were mounted between a stationary mount and a force-displacement transducer in thermostatically controlled (at 37 °C) 10 ml tissue baths. UBSM tone was determined by measuring the phasic contraction baseline curve. Phasic contraction duration was determined by the half-width (width of contraction at 50% of the amplitude). To evaluate the stromatoxin-1 effect on the phasic contractions, a 5 min period prior to stromatoxin-1 application was analyzed for the controls, and another 5 min period was analyzed following 30 min of 100 nM stromatoxin-1 application. Results are summarized as means ± SEM for the n, the number of UBSM strips isolated from different rats (N=number of rats). Data were compared using paired Student's t test. A P-value less than 0.05 was considered statistically significant.
RNA Extraction, RT-PCR, and Sequencing
Total RNA was isolated from rat brain, intact UBSM tissue, and freshly dispersed UBSM single cells using the RNeasy Mini Kit (Qiagen, Hilden, Germany). The extracted RNA was reverse-transcribed into cDNA using M-MLV Reverse Transcriptase (Promega) and oligo d(T) primers. Specific primers for K V 2.1, K V 2.2, K V 4.2 and K V 9.3 were designed based on the cDNA complete sequences of rat genes in Genbank. Specific primer pair sequences are listed in Table 1 . The cDNA production was PCR amplified using GoTaq
Green Master Mix (Promega Co.) and specific primers for K V channel subunits. The PCR annealing temperature for each primer pair was optimized using a mastercycler gradient thermocycler (Eppendorf, Hamburg, Germany). Thirty cycles were used for detection from tissue samples and 35 cycles were used for isolated UBSM single cells. Negative control experiments for PCR were performed in the absence of the reverse transcriptase (-RT).
PCR products were purified using the GenElute ™ PCR Clean-Up Kit (Sigma-Aldrich Co.)
and sequenced at the University of South Carolina Environmental Genomics Facility for sequence confirmation.
Western blot
Brain and UBSM proteins were extracted as previously described (7). Western blot was performed as follows: the protein was mixed with 5X Laemmli buffer (1:4) and denaturized for 5 min at 95 °C. Subsequently, equal amounts of brain and UBSM proteins (~50 μg) were loaded into adjacent lanes, subjected to 4-20% pre-cast SDS-PAGE for 2.5 h at 20 mA, and transferred onto a PVDF membrane at 40 mA for 2 h using semi-dry blot.
The membrane was then blocked with 5% non-fat dry milk/TBST buffer for 1 h at room temperature, and the blots were incubated with the affinity-purified rabbit polyclonal 
Immunocytochemistry
For immunocytochemical studies, freshly isolated UBSM cells were dropped on a glass cover slip for settling for 1.5 h at room temperature before further processing as described below. UBSM cells were fixed with pre-warmed 4% paraformaldehyde and sat for exactly 
RESULTS
Isometric UBSM tension recording
Here, we sought to investigate whether a pharmacological inhibition of stromatoxin-1-sensitive K V channels with stromatoxin-1 leads to potentiation of the physiologically relevant spontaneous (myogenic) phasic and tonic contractions that normally increased during micturition to facilitate urine voiding. In addition to the bladder myogenic activity, the UBSM contractions are also modulated by neurotransmitters released from autonomic nerves located in the bladder wall. Since stromatoxin-1-sensitive K V channels are also located in the nerves (5, 22) , blocking them with stromatoxin-1 may cause neuronal cell membrane depolarization, and therefore release of excitatory neurotransmitters such as acetylcholine and ATP. To minimize effects caused by neurotransmitter release, all experiments, with the exception of the EFS-induced contractions, were performed in the presence of 1 µM tetrodotoxin (Sigma-Aldrich Co.), a neuronal Na + channel blocker. UBSM strips were pre-incubated for at least 10 min with 1 µM tetrodotoxin prior to stromatoxin-1 application. Isometric UBSM tension recordings of isolated UBSM strips showed that blocking the K V channels with stromatoxin-1 (100 nM) increased spontaneous phasic contraction amplitude, muscle force integral and tone without any effect on contraction frequency or duration (n=20, N=12; Fig. 1 ). Following stromatoxin-1 application, the maximal effects on the spontaneous phasic contraction amplitude, muscle force integral and tone were 127.0 ± 7.3 (P<0.005), 124.7 ± 7.5 (P<0.005), and 103.4 ± 1.4 (P<0.01), respectively (Fig. 1B) . The effect of stromatoxin-1 on the spontaneous contractility was not reversible after 10 washes of the preparations with fresh physiological saline solution (n=8; N=4). The stromatoxin-1 (100 nM)-induced contractions along with the spontaneous contractions of UBSM strips were completely inhibited by 1 µM nifedipine, an L-type voltage-gated Ca 2+ channels blocker (n=6, N=4).
To test the effect of stromatoxin-1 under conditions of sustained membrane depolarization, we used 20 mM KCl or 1 μM carbachol to depolarize the cells and induce high-amplitude phasic contractions. Stromatoxin-1 (100 nM) had no effect on any of the parameters of the UBSM contractions induced by 20 mM KCl or 1 μM carbachol ( Table 2) . Collectively, these experiments indicate that blocking the K V channels with stromatoxin-1, increases spontaneous UBSM myogenic activity due to membrane potential depolarization and thus activation of Ca 2+ entry via L-type voltage-gated Ca 2+ channels.
In the next experimental series, we sought to investigate whether UBSM K V channels sensitive to stromatoxin-1 modulate the neurogenic (EFS-induced) contractions of rat urinary bladder. This experimental series was conducted in the absence of tetrodotoxin. In fact, the tetrodotoxin (1 µM) sensitivity of the contractions was used as indicator for the neurogenic origin of the EFS-induced UBSM contractions, because 1 µM tetrodotoxin completely eliminates the EFS-induced contractions (n=5, N=4). EFS frequency-response curves were created by measuring the amplitude of the EFS-induced UBSM contraction at stimulation frequencies of 5, 7.5, 10, 12.5, 15, 20, 30, 40, and 50 Hz (Fig. 2) . After an initial EFS frequency-response curve was generated under control conditions, UBSM strips were pre-incubated for 30 min with 100 nM stromatoxin-1, and then a second EFS frequency-response curve was generated using the same EFS parameters as indicated above. We found that EFS frequency-responses of UBSM strips were significantly increased in the presence of stromatoxin-1 at all stimulation frequencies except 20 Hz (n=6, N=5; P<0.05; Fig. 2 ). The amplitudes of the EFS-induced contractions (expressed in percent ± SEM) in the presence of 100 nM stromatoxin-1 were as follows: 32. respectively. To confirm the stability of the preparations, we also performed time-controls including two runs of EFS-induced contractions without applying stromatoxin-1 (n=4, N=4). The second time-control (in the absence of stromatoxin-1) followed the pattern of the first one with a slight decrease in contraction amplitude at higher stimulation frequencies (50 Hz), which is an opposite effect of the observed increase in EFS-induced contractions by stromatoxin-1. This experimental series suggests that stromatoxin-1-sensitive K V channels also regulate the neurogenic UBSM contractions.
However, the stromatoxin-1-sensitive K V channels play more important role in contributing to the myogenic UBSM activity compared to the neurogenic contractions (compare Figs. 1 and 2 ). Using molecular biology techniques such as RT-PCR, Western blot, and immunocytochemistry, we next sought to investigate the molecular identity of the stromatoxin-1-sensitive K V channels that determine the myogenic and neurogenic contractions of the rat urinary bladder.
RT-PCR
RT-PCR experiments were conducted to detect the expression of mRNA messages for all four stromatoxin-1-sensitive channels-K V 2. (Fig. 3) . K V 4.2 channel mRNA message was not detected in whole UBSM tissue, even after the initial PCR sample was subjected to a second round of amplification. Negative control experiments performed in the absence of the reverse transcriptase (-RT) demonstrated an absence of genomic DNA contamination (Fig. 3) .
The presence of other cell types within the UBSM layer, such as neurons, fibroblasts, and vascular myocytes, may lead to a detection of K V channel subunits expressed in cell types other than UBSM cells. To eliminate contamination from other cell types, we applied single-cell RT-PCR experiments on freshly isolated UBSM cells (7) . Again, the single-cell RT-PCR confirmed the expression of mRNA messages for K V 2.1, K V 2.2 and K V 9.3 but not K V 4.2 channel (Fig. 3) . A lack of genomic DNA contamination in mRNA isolated from single UBSM cells was also confirmed by using the negative control reactions lacking the reverse transcriptase (-RT). RT-PCR purified products from whole UBSM tissue, freshly dispersed UBSM cells, and rat brain were sequenced to confirm their identity. The purified products were obtained from at least three separate samples. To detect if any proteins for K V 2.1, K V 2.2, K V 4.2 and K V 9.3 channels are expressed in UBSM, we next applied Western blot analysis and immunocytochemistry.
Western blot
By applying the commercial K V subunit-specific antibodies, the protein expression of K V 2.1 and K V 2.2 in whole UBSM tissue was confirmed using Western blot (Fig. 4) . The expected molecular weights for K V 2.1 and K V 2.2 proteins were ~130kDa and ~125kDa, respectively, consistent with the experimentally determined molecular weights (Fig. 4) .
Pre-absorption of the primary antibody with its antigenic competing peptide indicated the specificity of the antibodies for their intended epitope. Consistent with our RT-PCR data, no K V 4.2 protein was detected in whole UBSM tissue (Fig. 4) . In contrast, an apparent immunoreactive band was expressed in rat brain which was used as a positive control. The specific antibodies to K V 9.3 channel did not show any signal both in rat brain and whole UBSM (data not shown). This may be due to ineffectiveness of the anti-K V 9.3 antibodies used, because K V 9.3 channel protein was not detected (using same anti-K V 9.3 antibodies) in rat brain controls either.
Immunocytochemistry
To further verify the presence of K V 2.1 and K V 2.2 channels in rat UBSM, we applied immunocytochemical labeling of freshly isolated UBSM cells using confocal microscopy.
Freshly isolated UBSM cells had bright distinct edges under confocal phase contrast optics. Anti-K V 2.1 and anti-K V 2.2 antibodies specifically labeled the freshly isolated cells indicating cell membrane localization of the K V 2.1 and K V 2.2 channels (Fig. 5) . However, immunofluorescence staining was not detected for K V 4.2 channel in isolated UBSM cells (data not illustrated), which was consistent with our RT-PCR and Western blot experiments. The aforementioned results were carefully controlled for specificity using the omission of the primary antibody and absorption of the primary antibody by a competing peptide (Fig. 5) .
DISCUSSION
The present study reveals that K V 2 channel subfamily with both of its members, K V 2.1 and K V 2.2, plays a fundamental role in the control of rat UBSM function. Several lines of evidence suggest that stromatoxin-1-sensitive K V 2.1 and K V 2.2 channels are the functional and molecular basis of a key regulatory mechanism in rat UBSM myogenic and neurogenic contractions.
First, stromatoxin-1, a specific inhibitor for K V 2.1, K V 2.2, K V 4.2 homomultimeric channels and K V 2.1/9.3 heteromultimeric channel, significantly increased spontaneous phasic contraction amplitude, muscle force integral and tone in isolated UBSM strips.
However, stromatoxin-1 had no effect on the UBSM contractions induced by 20 mM K + or 1 μM carbachol, indicating that under conditions of sustained membrane depolarization, the K V channels sensitive to stromatoxin-1 have no further contribution to the membrane excitability and contractility. Under normal physiological conditions, the K V channels overcome a physiologically relevant depolarization that appears during an action potential.
In our experimental series, we have created artificial conditions of sustained depolarization such as maintaining high concentrations of K + or carbachol in the bath solution. Under such conditions, the cell membrane remains constantly depolarized. The high external K + decreases the driving force for K + and changes the K + reversal potential. In addition, the K V channels rapidly inactivate under conditions of depolarization, which further reduces their activity. Our data support such a role for K V channels in rat UBSM. Carbachol, a chemically stable analog of acetylcholine, resistant to the activity of acetylcholinesterase, maintains constant depolarization unlike the transient depolarization induced by physiological release of the neurotransmitter acetylcholine. Our findings are also supported by recent studies suggesting that the K V channels are potential candidates in modulating the repolarization and after-hyperpolarization phases of UBSM action potentials and the resting membrane potential (8, 12, 28) . However, in a recent study by Suzuki's group (13), they reported no effect of stromatoxin-1 on the action potential or resting membrane potential in mouse UBSM using intracellular recordings. Species differences are the most likely reason for such discrepancy in their results and those obtained in our hands. Our observation is also in agreement with Nelson's group (28) who suggest that in mouse UBSM cells, Kv2.1 subunits do not form homotetramers and that this is consistent with a lack of stromatoxin-1 sensitivity. Finally, it is of concern that the Suzuki's conclusion (13) is based on data obtained only from 3 preparations that were pretreated with charybdotoxin.
The significant increase in the amplitude of the EFS-induced contractions over a wide range of stimulation frequencies (5-50 Hz) under conditions of blocked K V channels with stromatoxin-1 indicates an additional role for these channels in the nerve-evoked contractions. By decreasing membrane excitability, these channels oppose the activation of UBSM contractions in response to excitatory cholinergic and purinergic nerves. The conclusions drawn from our study are based on the K V 2.1, K V 2.2, K V 2.1/9.3 and K V 4.2 specific inhibition by stromatoxin-1, which is confirmed to be the inhibitor with the highest selectivity of K V 2.1 channel and the first known specific inhibitor for the K V 2.2 channel (9, 10, 25). Stromatoxin-1 is a member of a structural family with a short peptide reticulated by disulfide bridges and the functional mechanism of this toxin is to inhibit K V channels by specific modification of their gating kinetics (9, 10, 25) . A pharmacological dissection of K V 2 channels with stromatoxin-1 has also been performed on neurons (5, 25) and cerebral arteries (2) . These previous studies have confirmed the high usefulness of stromatoxin-1 for the study of neurological disorders and arterial dysfunction associated with a functional role of K V 2 channels.
Second, our combined molecular biology approach indicates the presence of K V 2.1 and Only the K V 4.3L transcript was identified in rat UBSM suggesting that maybe the K V 4.3L but not K V 4.2 contributes to regulation of rat UBSM contractility (18) .
PERSPECTIVES AND SIGNIFICANCE
Two important conclusions may be drawn from our study: 1) Stromatoxin-1-sensitive K V 2.1 and K V 2.2, but not K V 4.2, channels are expressed and are functional in rat UBSM;
2) K V 2 channels oppose both myogenic and neurogenic constriction of rat UBSM with primary effect on the myogenic component. Collectively, our findings provide compelling evidence to support that K V 2 channels are physiologically relevant regulators of urinary bladder function. Furthermore, a better understanding of K V 2 channels is crucial to developing new therapeutic strategies for treatment of overactive bladder. In fact, the K V 2 channels may represent an opportunity for novel pharmacological manipulation of the bladder because drug-induced opening of the K V 2 channels should decrease bladder contractions in contrast to the effect of stromatoxin-1.
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This study was supported by the National Institutes of Health DK070909 and DK084284 to Georgi V. Petkov. Tables   Table 1. RT-PCR primers for K V channels sensitive to stromatoxin-1 and tone in isolated UBSM strips. Spontaneous contractions were taken to be 100%.
Values are means ± SEM (n=20, N=12; **P<0.01; ***P<0.005). The results were verified in 3 separate Western blot reactions using proteins isolated from 3 rats. 
